Related Experiment Video
Updated: Jul 8, 2026
10:50
Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics
Published on: July 16, 2018
Differential exoprotease activities confer tumor-specific serum peptidome patterns
Josep Villanueva1, David R Shaffer, John Philip
1Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
The Journal of Clinical Investigation
|January 6, 2006
Summary
Researchers identified a unique set of serum peptides that accurately distinguish between cancer patients and healthy individuals. These peptide patterns, linked to protease activity, show potential as cancer biomarkers for early detection and classification.
Area of Science:
- Biochemistry
- Proteomics
- Biomarker Discovery
Background:
- Serum polypeptide patterns identified by mass spectrometry (MS) show potential as disease biomarkers.
- Wider acceptance requires understanding peptide components and their generation mechanisms.
Purpose of the Study:
- To identify and characterize serum peptide signatures for accurate cancer classification.
- To link these peptide profiles to underlying protease activity.
Main Methods:
- Utilized optimized peptide extraction and matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF) MS.
- Performed targeted sequence identification of 61 signature peptides.
Main Results:
- A limited subset of serum peptides accurately discriminated between patients with 3 solid tumors and controls.
- Identified peptides are generated by exopeptidase activities, showing cancer type-specific differences.
- Validated the predictive power of these peptide markers on an external prostate cancer dataset.
Conclusions:
- Established a direct link between disease peptide profiles and differential protease activity.
- Demonstrated the clinical utility of these peptide patterns as surrogate markers for cancer detection and classification.
- Highlighted implications for future peptide biomarker discovery efforts.
